In our analysis, these 12 brokerage accounts stand out as the best choices for stock trading, due to their low fees, strong platforms and quality customer support. Many, or all, of the products ...
Ladenburg Thalmann has recently reduced BioNano Genomics Inc (BNGO) stock to Neutral rating, as announced on November 15, 2024, according to Finviz. Earlier, on September 10, 2024, BTIG Research had ...
SAN DIEGO - Bionano Genomics , Inc. (NASDAQ:BNGO), currently valued at $20.9 million in market capitalization, announced ...
On Tuesday, BioNano Genomics Inc (BNGO) stock saw a decline, ending the day at $0.21 which represents a decrease of $-0.01 or -4.55% from the prior close of $0.22. The stock opened at $0.22 and ...
Bionano Genomics (BNGO) announced publication of a case study from the Shenzhen Maternity and Child Healthcare Hospital, China, demonstrating ...
Revenues are expected to grow 30-33% in the fourth quarter of 2024 compared to the $6.1 million in revenues for the third quarter of 2024.
Revenues for the fourth quarter 2024 are expected to be in the range of $7.9 million to $8.1 million, an estimated decrease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback